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INTRODUCTION 
Hemorrhagic diseases in swine have occurred sporadically in the past, 
and in 1969 and 1970 outbreaks of unusually large proportions were observed 
in Iowa and surrounding states. The syndrome was characterized by acute 
onset with lethargy, anorexia, lameness, hemorrhagic diarrhea, and death. 
Gross lesions in swine dying of porcine hemorrhagic disease were anemia, 
hemarthrosis, subcutaneous hematomata, intermuscular hemorrhages, and gas­
trointestinal bleeding. The blood characteristically failed to coagulate 
for as long as 12 to 72 hours. Preliminary clinical-pathologic examina­
tions disclosed anemia and elevated prothrombin times, while platelet num­
bers and liver function tests were normal. 
Prominent epizootiological features of the hemorrhagic disease 
included high incidence in weanling swine consuming pelleted feeds which 
contained antibiotic-sulfonamide drug combinations. Furthermore, hemor­
rhagic manifestations were ameliorated by administration of vitamin K. 
Mycotic cultures from suspect diets revealed several species of Aspergilli, 
but aflatoxin was not isolated from the feeds. 
Experimental reproduction of the disease was accomplished by feeding 
suspected rations to swine under controlled conditions. Examination of 
coagulation factor activity revealed a hemostatic deficiency pattern simi­
lar to field cases of hemorrhagic disease and characteristic of warfarin 
poisoning or vitamin K deficiency. 
Hemorrhage-inducing feeds were determined chemically to contain no 
warfarin or aflatoxin. However, compounds of molecular weight intermediate 
between aflatoxin and warfarin were isolated. The possibility of a natu­
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rally occurring mycotoxin with anti-vitamin K activity similar to dicoumarol 
was suggested. 
Research and clinical reports from human and veterinary medicine 
reflect conflicting evidence regarding the role of oral antibiotics in 
the production or exacerbation of vitamin K deficiency. Some investigators 
felt that antibiotic feeding could reduce vitamin K synthesis by intestinal 
microflora to a dangerously low level when prothrombin reserve was par­
tially depleted by other conditions. Vitamin K requirements in young anti­
biotic-fed swine were not well established. Since warfarin poisoning could 
cause a clinical and pathological condition similar to this hemorrhagic 
disease, it seemed reasonable that an antibiotic influence upon warfarin 
poisoning could be related to the potential role of antibiotic feeding in 
spontaneous porcine hemorrhage. Evidence from the literature also indi­
cated that warfarin can interact with or be influenced by many drugs, 
including antibiotics and sulfonamides. The activities of drug interac­
tion, plasma protein binding, or enzyme induction had not been observed for 
warfarin and antibiotics in swine. 
An experimental study was undertaken to determine the relationship of 
antibacterial feeding to exacerbation or alteration of vitamin K responsive 
hemorrhaging in swine. Specific objectives of the study were as follows: 
1. Develop the use of warfarin as a model for induced hemorrhage in 
swine in order to simulate potential naturally occurring hypoprothrom-
binemia. 
2. Determine a minimum clinically toxic dosage of warfarin in swine. 
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3. More fully characterize the clinical, hematologic, and pathologic 
changes in swine exposed to warfarin with comparison to other hemorrhagic 
diseases of swine. 
4. Investigate the effect of normal feeding levels and high levels of 
oral antibiotics and sulfonamides on standard measures of blood coagulation 
activity. 
5. Demonstrate whether any potential detrimental effect on blood 
coagulation occurs in swine exposed to a vitamin K antagonist (warfarin) 
and antibacterials concurrently. 
6. Measure changes in plasma levels of warfarin when sulfonamide is 
used as a potential enzyme inducer. 
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REVIEW OF LITERATURE 
Field and Experimental Porcine Hemorrhagic Diseases 
In the period from October, 1967, to April, 1971, 28 instances of a 
porcine hemorrhagic condition were reported to the Iowa Veterinary Diagnos­
tic Laboratory. The majority of these were accompanied by submission of 
porcine tissues or animals for examination. The incidence, clinical signs, 
lesions, and hematologic studies of those swine were reported by Osweiler 
ejt (1970). The disease was characterized by either acute onset of 
lameness and subcutaneous swelling or by high mortality in barrows from 
post-castration hemorrhage. 
Similar outbreaks were described in Nebraska by Fritschen £t al. 
(1970) and in Missouri by Muhrer e^ al. (1970). In the incidences 
described, the hemorrhage appeared to be caused by a clotting mechanism 
defect similar to hemophilia or dicoumarol poisoning. Osweiler e^ al. 
(1970) reproduced the disease in weanling swine by feeding the diet col­
lected from a farm with affected svrine. The condition ijas characterized 
by prolonged clotting time, elevated One-Stage Prothrombin Time (OSPT), 
and prolonged Activated Partial Thromboplastin Time (APTT).^ A probable 
deficiency of Factor VII or Factor X was indicated. The hematologic and 
clotting factor changes were suggestive of vitamin K deficiency or warfarin 
poisoning as described by Deykin (1.970a). 
Deykin (1970a) reviewed the functions of vitamin K in the synthesis of 
procoagulants. He stated that Factors II, VII, IX, and X are dependent 
Clinical Pathology Laboratory, McFarland Clinic, Ames, Iowa. 
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upon vitamin K activity for their synthesis. Furthermore, at high doses of 
warfarin or dicoumarol, synthesis of the same procoagulants ceases. 
Rowsell (1968) stated that coagulation factor activity in swine is identi­
cal to that in man for standard test systems when considering Factors V, 
VII, and X and that coagulation factor activity for Factor IX is slightly 
increased for swine, 
Didisheim et^ al. (1959) studied the effects of various sources of 
brain tissue thromboplastin upon different species of animals in studying 
coagulation factors and prothrombin time. The pattern of coagulation fac­
tor deficiencies observed in human patients with warfarin overdosage, ani­
mals with vitamin K deficiency, and the swine from field cases reported by 
Osweiler e^ al. (1970) were similar. 
Porcine hemorrhage was reproduced by Muhrer e^ al. (1970) and by 
Fritschen et (1970) by feeding suspect diets from field cases. The 
clinical signs reported by Osweiler £t (1970) and by Fritschen e^ al. 
(1970) were halted by administration of menadione sodium bisulfite therapy 
at 2 gm/ton of feed. 
Epizootiological factors considered important in the onset of this 
condition were as follows: 
1. Swine involved were primarily of weanling age and were consuming 
increasing amounts of feed. 
2. Nearly all of the rations were pelleted complete feed. 
3. Antibiotics were added to the feed with tylosin and sulfamethazine 
combinations most often used. 
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Related Diseases Characterized by Hemorrhage 
Numerous outbreaks of disease with hemorrhagic manifestations have 
been reported in domestic animals. Schofield (1924) reported on a disease 
of cattle resembling hemorrhagic septicemia and blackleg. Subsequent stud­
ies revealed that the disease was associated with molded sweetclover hay. 
The mold was not toxic alone but only when associated with sweetclover. 
Link (1944) confirmed the association of sweetclover disease with molded, 
improperly cured hay. He isolated the toxic principle, later named 
dicoumarol, and elucidated its structure as 3,3'-methylene bis (4-hydroxy-
coumarin). Application of dicoumarol to rodent control and human thrombo­
embolic cardiovascular disease resulted from these early findings according 
to Levine (1970). 
A moldy corn toxicosis characterized by hematomata and intramuscular, 
renal, and hepatic hemorrhage was reported by Albright et al. (1964). How­
ever, hepatic lesions and lack of reponse to vitamin K were features of 
Ll.lo disease. 
Intestinal hemorrhage in swine was reported by Jones (1967) and char­
acterized as an acute disease with extensive hemorrhage into the lumen of 
the small intestine in pigs 2 to 5 months in age. The disease was believed 
to be a hypersensitivity reaction or vitamin E deficiency. A hemorrhagic 
bowel syndrome was reported by O'Neill (1970) and by Van Ulsen (1971)= 
Both workers discounted the possibility of infectious agents, most speci­
fically Clostridium perfringens. Van Ulsen (1971) suggested a possible 
relationship to Scopoletin (7-hydroxy-6-methoxy-cumarin) which is found in 
various plants throughout nature. 
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Muhrer et al. (1942) studied an apparent hemophiliac-like disease in a 
strain of experiment station swine. In his work no dietary relationship 
was shown, and the condition was ascribed to a probable inherited Factor 
VIII deficiency. 
The role of fungal toxins has been suspect in instances of hemorrhagic 
disease. Hesseltine (1969) reviewed the literature regarding mycotoxicoses 
in animals. Specific lesions of hemorrhage and elevated prothrombin time 
were noted only for a toxin from corn invaded by Chaetomium globosum. 
Christensen ejt (1966) reported that swine and rats were not susceptible 
to the Chaetomium toxin. Hamburg e^ (1968) isolated toxic spiroepoxy 
compounds from Fusarium tricinctum and observed internal hemorrhages caused 
by feeding the toxin to rats. Speer (1971) reviewed some conditions and 
possible toxins associated with mycotoxicosis and hemorrhage in swine. He 
indicated that field shelling of corn, recently increased in the Midwest, 
enhanced its vulnerability to storage fungal growth. Speer (1971) noted 
that a scirpencl-like compound was isolated from swine feeds associated 
with hemorrhagic disease reported by Osweiler et al. (1970). Bababunmi and 
Bassir (1969) determined an effect of aflatoxin on blood coagulation in 
the rat. The extrinsic system of coagulation was found defective in a pat­
tern similar to changes induced by warfarin. 
Matschiner and Doisy (1962) found a tendency for vitamin À to increase 
the clinical signs of vitamin K deficiency in rats as measured by a 
decreased prothrombin activity. 
Natural and experimental warfarin poisoning in swine has been studied 
in a limited manner. Warfarin poisoning in swine was reported by Frazier 
(1966). The disease was characterized by lameness, weakness, normal appe­
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tite, and hemorrhages on the pelvic musculature and under the renal cap­
sule. McGirr and Papworth (1955) studied warfarin poisoning in various 
species including the pig. Swine were found susceptible to warfarin admin­
istered at 0.37 mg/kg body weight for six days. Symptoms and lesions were 
variable but included inappetence, hematomata, lameness, and bloody feces. 
Articular and intramuscular hemorrhage were the most common lesions. 
Mushett and Seeler (1947) studied the effect of sulfaquinoxaline on 
rats after removal of the gastrointestinal tract and found suppression of 
prothrombin activity within 24 hours after administration of the drug. 
Sulfanilamide and sulfamerazine failed to produce hypoprothrombinemia 
within four weeks. When the surgically treated rats were not given sulfa­
quinoxaline, the body stores or prothrombin appeared sufficient for several 
days. The authors suggested that these results indicated a direct effect 
of sulfaquinoxaline on the prothrombin complex. They also noted that 
sulfonamides, by nature of their antibacterial activity, might indirectly 
cause vitamin K deficiency by curtailing synthesis of vitazin K in the 
intestine of animals fed vitamin K-deficient diets. 
Griminger (1957) suggested that oral sulfaquinoxaline-induced hypo­
prothrombinemia could be reversed by vitamin K. Griminger and Donis (1960) 
demonstrated that vitamin would effectively reverie sulfaquinoxaline-
induced hypoprothrombinemia of poultry. Menadione sodium bisulfite was 
found by Griminger (1965) to be as effective as vitamin in reversing the 
hypoprothrombinemic effect of sulfadimethoxine. Nelson and Norris (1959) 
found that in poultry menadione sodium bisulfite corrected clotting time 
but not hemorrhages. 
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Dempsey and Sanford (1960) and Sadek (1955) observed hemor­
rhages in poultry when various levels of antibiotics were fed. Buck (1969) 
reviewed hemorrhagic diseases of poultry and concluded that the two prob­
able factors involved are hypoprothrombinemia and thrombocytopenia. He 
cited evidence indicating that stress factors including drugs or antibio­
tics may be directly or indirectly implicated. 
Forgacs et al. (1958), Hinshaw (1956), Schumaier et al. (1961), and 
Forgacs and Carll (1955) reported on possible relationships of mycotoxins 
to hemorrhagic disease in poultry. 
Vitamin K Deficiency in Livestock and Poultry 
Induced hypoprothrombinemia in animals and man is generally regarded 
as a result of vitamin K deficiency from several possible causes. Finkle 
(1961), Rowsell (1968), and Deykin (1970a) stated that vitamin K is 
responsible for hepatic synthesis of clotting factors II (Prothrombin), 
VII (Proconvertin), IX (Plasma Thromboplastin Component), and X (Stuart-
Prower Factor). Thus, any condition interfering with synthesis, absorp­
tion, or utilization of vitamin K will be manifest as a decrease in clot­
ting factor activity. Green (1966) listed possible causes of vitamin K 
deficiency, including sulfaquinoxaline intake, dicoumarol anticoagulant 
therapy, ulcerative colitis, sprue, obstructive jaundice, hepatic damage, 
and vitamin A excess. 
Dam £t £l. (1937) found that rats, dogs, and guinea pigs were resistant 
to dietary vitamin K deficiency. Green (1966) stated that a practical 
method for inducing vitamin K deficiency in the rat was via supplementation 
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of the diet with sulfaquinoxaline or a similar drug. His rationale was 
that sulfonamides inhibit microbial synthesis of vitamin K. 
Greaves (1939) created a surgical shunt of the bile duct to the colon 
in rats and produced hemorrhage in rats given a vitamin K-deficient diet. 
The rats continued to excrete fecal vitamin K even when fed a vitamin K-
deficient ration. Cover et. al. (1955) cited evidence that avitaminosis K 
in the chick was caused by a diet low in vitamin K combined with prevention 
of coprophagy. This view is supported by Deykin (1970a) who extensively 
reviewed the anticoagulant literature and concluded that the two primary 
sources of vitamin K are diet and intestinal microflora. 
Porter (1946) ascribed vitamin K potencies to various bacteria. In 
relation to an alfalfa standard, Escherichia coli was 3 times as potent 
for vitamin K as was alfalfa, while Bacillus subtilis was 38 times more 
effective than alfalfa as a vitamin K source. Almquist et^ al. (1938) also 
demonstrated an antihemorrhagic factor in E^. coli and subtilis. Goodwin 
(1903) and Isler and wiss (1959) felt that the bacterial synthesis of vita­
min K depended on the composition of intestinal bacterial flora. Castle 
(1967) and Almquist e_t al. (1938) expressed the traditional view that in 
man vitamin K is ordinarily obtained from bacterial action in the intestine, 
and little is required from the diet. Barnes ejt al. (1959) experimentally 
demonstrated that rats resist dietary vitamin K deficiency by consuming 
their own feces. Coprophagy prevention for two weeks resulted in a rise in 
prothrombin time. Mameesh and Johnson (1959) also found that coprophagy 
prevention in rats on a purified diet greatly exacerbated vitamin K defi­
ciency. They suggested that vitamin K was not absorbed from the lower 
intestine or colon but must be ingested and absorbed at higher enteric 
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sites. Scott (1966) stated that the most important factor modifying the 
dietary vitamin K requirement is the synthesis of vitamin K by gastrointes­
tinal microflora. Gustafsson e^ £l. (1962) fed E^. coli and Sarcina-like 
micrococci to vitamin K-deficient germ-free rats and reversed vitamin K 
deficiency withn from 24 to 48 hours. 
The role of antibiotics in vitamin K deficiency has been of interest 
in various species. Schendel and Johnson (1962) studied the vitamin K 
requirements of young swine. Pigs fed a purified diet deficient in vita­
min K developed signs of hypoprothrombinemia, which could be prevented by 
administration of menadione sodium diphosphate at 5 p,g/kg body weight daily. 
The use of sulfathiazole at 5 gm/kg of dry feed or oxytetracycline at 
60 mg/kg of dry feed did not conclusively influence the onset of vitamin K 
deficiency in the pig. Griminger (1965) found that in chicks fed low lev­
els of vitamin K the inclusion of tetracycline caused a significant 
increase in severity of hemorrhages in poultry suffering from hemorrhagic 
disease. Similar effects were obtained for zinc bacitracin and oxytetra­
cycline. 
Haden (1957) described a human patient on heavy post-operative anti­
biotic therapy who developed an elevated prothrombin time and Factor VII 
deficiency after 12 days of treatment. Response to vitamin therapy was 
good. Kabins (1972) concluded that tetracycline, ampicillin, and other 
oral antibiotics could cause suppression of intestinal synthesis of vita­
min resulting in the hypoprothrombinemia of vitamin K deficiency. 
Koch-Weser and Sellers (1971b) extensively reviewed work in the area 
of drug interactions and concluded that the contribution of bacterial vita­
min K synthesis is important when dietary intake of vitamin K is restricted. 
12 
They postulated that the hypoprothrombinemic state in patients on coumarins 
might be potentiated by antibiotic-induced reduction of microfloral synthe­
sis of vitamin K. This could happen even though the antibiotic does not 
increase the prothrombin time of normal subjects. 
In man, potentiation of drug-induced anticoagulant effect has been 
shown for chloramphenicol, chlortetracycline, neomycin, and sulfonamides. 
Koch-Weser and Sellers (1971a) cited evidence that chloramphenicol retards 
the transformation of bishydroxycoumarin, while neomycin results in 
decreased absorption of vitamin K. In man, they found no evidence of sul­
fonamides decreasing intestinal bacterial synthesis of vitamin K. Kabins 
(1972) reviewed evidence that sulfonamides affect plasma binding of oral 
anticoagulants and enhance their efficacy. 
Antibiotic Toxicity in Swine 
Numerous studies of antibiotics in swine rations have been conducted. 
Of these, very few have involved a study of the coagulation system itself. 
Anderson £_t al. (1965) reported on the toxicologic properties of tylosin. 
Rats were given 10,000 parts per million tylosin in the feed for two 
years with no significant changes in growth, viscera, or hematology. Dogs 
were able to tolerate 400 mg/kg/day for 2 years with no visceral damage. 
Studies of the hematologic changes in dogs were not reported. Mayrose 
et al. (1966) studied the effects of tylosin on swine reproduction. 
They fed tylosin at 220 mg/kg of feed for 1 week pre-mating to 3 weeks 
after mating. The pigs were weaned with a greater weaning weight than lit-
termate controls. No effect on blood components or hemostasis was indi­
cated. Jordan and Waitt (1963) administered 500 mg of tylosin per day to 
13 
sows for 5 days pre-partiun until 2 weeks post-partum. A higher percent­
age of pigs from tylosin-fed sows survived, but no report was given on 
the hematologic effects of tylosin. Melliere £t al. (1968) fed sulfametha­
zine alone and sulfamethazine in combination with tylosin and observed an 
increase in gain significant to the 0.05 level. No data on hematology was 
obtained. Conrad and Beeson (1960) observed the effects of chlortetracy-
cline and oxytetracycline at high levels in a protein supplement for grow­
ing and finishing swine. They noted increased feed intake and gain and 
increased average daily gain at ranges of 50 to 250 gm/ton. No effect on 
blood coagulation or other hematologic factors was observed. Hays and 
Speer (1960) studied the effect of spiramycin on growth and feed utiliza­
tion in swine and compared its effect to aureomycin and oxytetracycline. 
No report on hemostatic effects nor hematologic evaluation was given. 
There appears to be a relative lack of studies of the coagulation fac­
tors and hemostatic function mechanisms in swine, specifically with regard 
both to vitamin K deficiency and the effects of antibiotics or. the produc­
tion of vitamin K by intestinal bacteria. The studies of Schendel and 
Johnson (1962) appear to be the only specific work regarding antibiotics 
and their effect on vitamin K deficiency in young swine. 
Drug Effects on Coumarin Anticoagulants 
Drugs may alter the effect of coumarin anticoagulants. Koch-Weser and 
Sellers (1971a) summarized the ways in which coumarin and drug interactions 
may be influenced as follows; 
1. The bioavailability of vitamin K may vary as in decreased bacte­
rial synthesis of vitamin K. 
14 
2. The metabolic fate of coumarins may be modified by such things as 
absorption, protein binding, biotransformation, and excretion. 
3. Prothrombin complex synthesis or catabolism may be altered. 
4. The receptor affinity for coumarins at their site of action may be 
influenced. 
5. Nonprothrombin-dependent hemostatic mechanisms may be changed. 
Deykin (1970b) reviewed the literature concerning therapy with the 
anticoagulant drug warfarin and concluded that drugs can influence the 
response of patients to warfarin. A drug may displace warfarin from its 
binding site and increase the concentration of free warfarin, or the affin­
ity of receptor sites for coumarin or warfarin may be changed. There may 
also be competition between drugs for degradation sites on the endoplasmic 
reticulum, suppression of degradative enzymes by an administered drug, or 
increases in enzymes associated with the endoplasmic reticulum. Changes in 
the protein synthesis mechanism and impaired thrombocyte function are other 
possible drug effects. 
Conney (1969) in reviewing drug metabolism and therapeutics observed 
that chronic administration of s drug can enhance the metabolism of other 
drugs or increase its own metabolism after a period of continued adminis­
tration. He stated that induction of microsomal liver enzymes, especially 
in the endoplasmic reticulum, can change the effect of a specific drug when 
multiple agents are administered. 
Coumarin drugs are metabolized at widely varying rates. Conney (1969) 
and Solomon (1969) studied variations in the metabolism of coumarin anti­
coagulant drugs. They reported that there may be a genetic difference in 
the ability of subjects to metabolize warfarin. Solomon (1969) found that 
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the metabolism of warfarin and bishydroxycoumarin is extensively carried on 
by hepatic microsomal enzymes. 
Nagashima and Levy (1969) studied the comparative pharmacokinetics of 
coumarin anticoagulants in the rat, dog, monkey, and man by following the 
half-life for plasma warfarin. They concluded that warfarin and bishydroxy­
coumarin are probably subject to the same major biotransformation pathways 
and that the half-life varies widely among species. They found further 
that warfarin concentrations in plasma decline exponentially with time in 
each species. However, there was a variation in the way individual species 
handled increased doses of warfarin. Conney (1969) stated that the acute 
toxicity of warfarin and bishydroxycoumarin in animals was reduced when 
phénobarbital was used as an inducing drug. 
Koch-Weser and Sellers (1971a) reported that coumarins are hydroxy-
lated by hepatic microsomal mixed-function oxidases. Several ring-hydroxy-
lated inactive metabolites of warfarin may be found in urine, and 7 
fluorescent chrcmatographically-separate compounds have been detected in 
the urine of warfarin-treated subjects. Hypoprothrombinemia was not influ­
enced by the hydroxylated form in rats. Four prime hydroxycoumarin was 
one-fourth uS potent as warfarin for the production of hypoprothrombinemia 
in the rat. These authors stated that in man the metabolites of warfarin 
have a negligible effect on prothrombin status. Ullrich and Staudinger 
(1968) confirmed that metabolism of warfarin in the rat involved transfor­
mation to 6, 7, and 8-hydroxy warfarin by liver microsomes and that NADPH 
and molecular oxygen were required. They also found that the metabolites 
of warfarin are pharmacologically inactive. 
16 
Koch-Weser and Sellers (1971a) concluded that individual differences in 
coumarin half-life reflect differences in the rate of biotransformation of 
the coumarin drug. Thus, the degree of induction by a drug is accurately 
reflected by the change in half-life of a coumarin provided no other meta­
bolic interaction is present. About one week of exposure to an inducing 
agent may be required for maximal induction in most cases. When the 
inducer is withdrawn, several weeks are needed to return to normal status 
as compared to controls. 
The binding of coumarin drugs to plasma proteins may be a significant 
factor in the response of animals to doses of anticoagulant coumarin drugs. 
Koch-Weser and Sellers (1971a) reviewed the plasma binding of warfarin and 
other coumarin drugs. They found that coumarins are bound to plasma pro­
teins and become pharmacologically inactive, protected from biotransforma­
tion and excretion, and excreted only when the unbound drug is available in 
the plasma in equilibrium with its site of action. Only unbound drug is 
susceptible to glomerular filtration. The interaction of warfarin with 
plasma albumins and globulins largely partitions the warfarin into the 
plasma, and binding to plasma proteins involves approximately 97 percent of 
the total drug in the plasma. Albumin binding is readily reversible, and 
the total plasma-bound reservoir is gradually released as biotransformation 
lowers the concentration of free drug. 
Koch-Weser and Sellers (1971a) found no drugs which enhance coumarin 
binding. They reviewed the mechanism by which drugs displace coumarin from 
binding sites in the plasma and thereby potentiate its hypoprothrombinemic 
action. Displacing drugs may either compete with coumarin for the same 
binding sites on albumin or bind to albumin at sites remote from coumarin 
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action but which induce tertiary structural changes in the albumin preclud­
ing or decreasing coumarin binding. Drugs or metabolites which displace 
coumarin are generally accumulated to high levels in the plasma. Most of 
the important displacing drugs are acidic compounds with an ionized acidic 
group at physiological pH. Because all coumarins are highly bound, dis­
placement of even a small amount of coumarin causes a large increase in 
free drug concentration, thus markedly enhancing toxicity. Administration 
of strongly displacing drugs to individuals continuously exposed to cou­
marins may markedly increase concentration of free coumarin and cause 
severe hypoprothrombinemia and bleeding. 
Increased displacement of warfarin makes a greater amount of drug 
available for hepatic biotransformation and glomerular filtration. This 
shortens the plasma half-life, and excretion may exceed intake, with the 
result that plasma concentration declines. The effect of high initial free 
coumarin concentrations may be offset by an increased rate of coumarin 
ir^mOVoL • 
A number of drugs are known to increase the displacement of warfarin 
from the plasma binding sites. Aggeler et al. (1967) reported that phenyl­
butazone administration significantly decreased the plasma concentration 
and biological half-life of warfarin, but the anticoagulant effect was 
increased markedly. They felt that phenylbutazone displaced warfarin from 
human plasma albumin binding and acted to increase the effect of warfarin 
by making greater quantities of free warfarin available to drug metaboliz­
ing enzymes or to biologic action sites. 
Sher (1971) reviewed the literature and tabulated an extensive list of 
drugs associated with enzyme induction and drug interactions. Included 
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among these were drugs which caused displacement of warfarin from plasma 
albumin binding sites. Both phenylbutazone and tolbutamide were found to 
decrease the binding of coumarins to plasma proteins. The potentiation of 
coumarin by tolbutamide in dogs was followed by decreased sensitivity to 
anticoagulant associated with very low levels of plasma coumarin. This 
latter stage was probably due to a stimulatory effect of tolbutamide on 
warfarin metabolism. Solomon et. âi.* (1968) found that phenylbutazone 
decreased plasma warfarin half-life by binding to the same site on plasma 
protein. Sher (1971) included sulfonamides among the drugs listed as caus­
ing displacement of warfarin from plasma binding sites. 
Sher (1971) listed drugs which antagonize the action of warfarin via 
their effect on hepatic microsomal enzyme induction. Included among these 
were phénobarbital and pentobarbital. Ullrich and Staudlnger (1968) also 
found that pre-treatment of rats with phénobarbital increased the rate of 
3-hydroxylation reactions of warfarin. Welch al. (1969) studied the 
interaction of drugs with bishydroxycoumarin in dogs. They found that 
phénobarbital caused a decrease in prothrombin time and plasma bishydroxy­
coumarin concentration after 9 days on phénobarbital. When phénobarbi­
tal was removed, none was detectable in the blood after 3 days, but the 
depression of prothrombin time and bishydroxycoumarin concentration con­
tinued for 6 to 10 days, Kabins (1972) reviewed evidence for increased 
warfarin metabolism after griseofulvin administration resulted in hepatic 
enzyme stimulation. 
Stowe (1965), reviewing the metabolism and excretion of sulfonamides, 
stated that phenylbutazone competes with sulfonamides and with warfarin for 
plasma binding sites. He found that the main metabolic site for sulfo-
19 
namides is the liver. Acetylation is the most important form of metabolism, 
and acetylated derivates are therapeutically inactive and less soluble, 
A secondary pathway involves oxidation of the benzene ring of sulfonamides 
to a quinone structure which is then reduced to a hydroxylated form. The 
phenolic group formed is conjugated, either with sulfate or with glucuronic 
acid. Both of these are therapeutically inactive. 
Dalgaard-Mikkelsen e_t (1953) studied the distribution of sulfathi-
azole and sulfamethazine in swine. They found high concentrations of 
sulfonamides in the kidney and liver. The degree of acetylation for sulfa­
methazine was greater than for sulfathiazole in each of the tissues. Stowe 
(1965) stated that protein binding is a major factor in the distribution of 
sulfonamides in the body fluids and tissues. Loss of the unbound fraction 
results in resupply from the bound portion. Thus, for both sulfonamides 
and warfarin, hepatic metabolism and plasma albumin binding appear to play 
a major role in the transformation, biologic activity, and excretion of 
these drugs. 
Robinson e^ (1971) investigated the interaction of warfarin and 
nonsystemic gastrointestinal drugs. They found that concomitant adminis­
tration of a second drug would alter the absorption of an anticoagulant. 
This could occur when intestinal pH or motility, drug solubility, and anti­
coagulant binding to the drug itself were changed as warfarin entered the 
small intestine and was rapidly converted to its anionic form. Thus, con­
sideration of enzyme induction effects must also take into account the pos­
sible diminished absorption of warfarin due to complexing in the intestinal 
lumen. 
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MATERIALS AND METHODS 
Experimental Swine 
Eighty-eight crossbred pigs ranging from 12.1 to 26.0 pounds in ini­
tial weight were utilized. Swine were obtained from the Iowa State Univer­
sity Swine Nutrition herd and from 2 commercial swine herds. All con­
trols and principals were confinement reared, weaned within the week prior 
to procurement, and prevented access to green forage, pasture, hay, or 
alfalfa meal. Animals were confined for seven days to accustom them to the 
new surroundings and ration. All swine were housed in concrete-floored 
pens which were cleaned and washed daily. 
To ensure complete consumption of the ration, feed was limited to 6 
percent of body weight daily in each pen. After selection of pigs for vari­
ous trials, the animals were weighed and placed in the appropriate pens. 
During the acclimation period, the experimental basic ration was made 
available to the swine. This ration was free of antibiotics until a time 
appropriate to each trial. The ration was a standard mixture.^ The for­
mula for this feed was as follows: 
Ingredients 
Experimental Ration 
Ground Yellow Corn 78.25 lbs 
50% Soybean Oil Meal 18.50 lbs 
Vitamin Premix 0.50 lb 
Swine Grower Ration, Swine Nutrition, Iowa State University, Ames, 
Iowa. 
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Calcium Carbonate 0.90 lb 
Dicalcium Phosphate 1.25 lbs 
Iodized Salt 0.50 lb 
Trace Mineral Mix 0.10 lb 
100.00 lbs 
Calculated Analysis 
Protein 16.14% 
Calcium 0.72% 
Phosphorus 0.54% 
Vitamin A 1532 I.U. 
Vitamin 300 I.U. 
Riboflavin 2.6 mg/lo 
Calcium Pantothenate 6.8 mg/lb 
Niacin 18.2 mg/lb 
Choline Chloride 407.0 mg/lb 
Vitamin ^ 10.0 mcg/lb 
Experimental Drugs 
Antibacterial drugs for the feeding trials were supplied by a commer­
cial company.^ The drugs used were tylosin phosphate at 100 grams (low 
level) and 1.000 grams (high level) per ton of feed and sulfamethazine 
sodium at 100 grams (low level) and 300 grams (high level) per ton of feed. 
The antibiotics were used in combination and were mixed in the feed supply 
at appropriate levels for the various trials. 
^Tylan^and Tylan-sulfa®, Eli Lilly and Company, Greenfield, Indiana. 
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Warfarin (3-[a-acetonylbenzyl]-4-hydroxycouniarin) was obtained as the 
pure reagent-grade compound.^ It was dissolved in ethanol and added to 
2 
cellulose powder to make a slurry. The mixture was evaporated at room 
temperature to leave a dry powder containing 1.0 percent warfarin on a dry-
weight basis. This preparation was stored in glass in a darkened cabinet 
at room temperature. 
Clinical and Sampling Methods 
All swine were observed twice daily for clinical signs of warfarin 
poisoning. Clinical response was recorded daily. When animals were judged 
to be beyond humane maintenance, euthanasia was performed. 
Blood samples were collected throughout the experiment utilizing an 
ocular bleeding technique described by Huhn et al. (1969). Blood was col­
lected at 1:10 dilution in 0.1 molar sodium oxalate and immersed in an ice 
bath immediately after collection. Plasma was separated from erythrocytes 
by centrifugation and removed to cold storage (4° C) within 30 minutes 
after collection. All laboratory procedures for coagulation factor activ­
ity were performed within 1 hour or less after collection, as recommended 
by Quick (1966). 
In those swine judged moribund, a blood sample was taken immediately 
before euthanasia, 
& K Biochemicals, Plainview, N.Y. 11803. 
2 
Brinkman Instruments, Westbury, N.Y. 11590. 
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Laboratory Procedures 
Blood coagulation time was determined using the Lee and White tech­
nique described by Benjamin (1961). The One-Stage Prothrombin Time (OSPT) 
developed by Quick (1966) and the Activated Partial Thromboplastin Time 
(APTT) described by Coles (1967) were used to assess the activity of vita­
min K-dependent or warfarin-sensitive coagulation factors. 
Correction tests utilizing barium sulfate-adsorbed plasma and aged 
serum were conducted by the technique of Sirridge (1967). Blood for this 
technique was collected from normal swine.^ Normal plasma and the correct­
ing reagents were examined for OSPT and APTT activity and stored in 3-ml 
aliquots. Correction tests were conducted using a fibrometer to detect 
2 
initial clot formation. 
Total protein and fibrinogen levels were determined with a protein 
refractometer according to the technique outlined by Benjamin (1961). 
Smears for differential leukocyte counts were made from fresh undi­
luted bleed ar.d evaluated by counting proportions of different white cells 
in 100 total leukocytes. Preparation and staining was according to Schalm 
(1965). 
Microhematocrit tubes were used as described by Benjamin (1961) to 
measure packed cell volume. Clot retraction was assessed by observation of 
the clotted blood sample in glass tubes at 2 and 24 hours after collection. 
1 
Meat Science Laboratory, Iowa State University, Ames, Iowa. 
2 
BBL Fibrometer, BIOQUEST, Cockeysville, Md. 21030. 
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Necropsy and Collection of Tissues 
Swine dying of hemorrhage were necropsied as soon as possible after 
death. Any pigs found moribund were stunned with electrical shock and 
euthanized by exsanguination. Where possible, blood was collected for 
analytical procedures. 
Tissues for histopathologic examination were collected and immersed 
in 10 percent buffered formalin. Portions of the brain, liver, kidney, 
lung, pancreas, stomach, intestine, colon, body lymph nodes, muscle, and 
subcutaneous tissue were taken. 
Histologic Procedures 
Tissues were fixed in 10 percent formalin, embedded in paraffin, sec­
tioned at 6 microns, and stained with hematoxylin and eosin. 
Statistical Evaluation 
Swine were selected from herds of origin either at random or for lit-
cer differences. Assignment of pigs to pens and treatments v:as at random 
using a table of random numbers from Snedecor and Cochran (1967). 
Statistical treatment of data from laboratory procedures was by analy­
sis of variance. F-values were determined from computed sums of squares 
and mean squares for litter, treatment, day, and day by treatment interac­
tion.^ Statistical significance was assigned to F-values according to 
Snedecor and Cochran (1967). Where missing data were encountered, a 
weighted analysis was computed. 
Statistical Laboratory, Iowa State University, Ames, Iowa. 
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Experimental Design 
Trial Establishment of ^  warfarin dose-response curve 
Ten weanling swine were selected and assigned at random to various 
peroral daily doses of warfarin on a milligrams per pound (mg/lb) of body 
weight basis. The levels were as follows: 
Niiniher of pigs Daily warfarin dose in mg/lb body weight 
1 0.00 
2 0.05 
2 0 .10 
2 0.15 
1  0 .20  
1 0.30 
1 0.50 
Pre-trial blood samples were taken and additional samples were drawn 
at 3-day intervals thereafter until completion of the trial. Pigs were 
observed for 14 days il death did not occur sooner. Measurements made 
included clotting time, One-Stage Prothrombin Time (OSPT), Activated Par­
tial Thromboplastin Time (APTT), packed cell volume (PCV), and differential 
leukocyte count. 
aose ic 
Four swine were given warfarin daily at levels of 0.0075 mg/lb for 
each of 2 animals and 0.0125 mg/lb for each of 2 animals. Similar clinical 
and laboratory procedures were conducted as for Trial 1. An attempt was 
made to select the dose of warfarin causing slight increase in coagulation 
time but no clinical hemorrhage. The trial was continued for 12 days with 
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samples taken before and at 3, 6, and 11 days after warfarin feeding 
started. 
Trial 2= The effect of high and low levels of tylosin-sulfamethazine com­
bination on pigs fed subclinical levels of warfarin 
Thirty-two swine were used in this trial. Four pigs were selected at 
random from each of 8 litters. Pigs of the same litter were assigned to 
pens of 2 each and each pen assigned to one of 4 treatments in a split plot 
design. 
The 4 treatment combinations in this experiment were as follows: 
Number of swine Treatment 
8 Warfarin + Low Level Tylosin-Sulfamethazine 
8 Warfarin + High Level Tylosin-Sulfametbazine 
8 Control + Low Level Tylosin-Sulfamethazine 
8 Control + High Level Tylosin-Sulfamethazine 
Warfarin at 0.0075 mg/lb body weight was fed daily to individual swine 
on a body weight basis which was redetermined weekly. Warfarin was sixad 
with a small amount of feed and hand fed to insure that consumption was 
complete. 
Parameters measured in this trial were coagulation time, OSPT, APTT, 
PCV, total protein, fibrinogen, and differential leukocyte count. One pig 
from each litter was euthanized and necropsy and histologic examinations 
conducted at the termination of the trial- Pre-trial and once-weekly blood 
samples were taken during the 28-day experiment. 
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Trial The effect of high feed levels of tvlosin-sulfamethazine on clin­
ical warfarin poisoning 
Changes in coagulation time, OSPT, APTT, clot retraction, and PCV were 
evaluated. Sixteen swine selected to account for random litter differences 
were utilized. Four pigs were selected at random from each source litter. 
The daily dosage of 0.025 mg warfarin per pound of body weight was mixed in 
a portion of the ration and hand fed individually to assure consumption of 
the dose. Blood was collected immediately before the trial and at 4, 7, 11, 
14, and 21 days thereafter. 
Clinical response, necropsy lesions, and histopathologic findings were 
recorded where appropriate to the affected animals. 
Trial The effect of high levels of tylosin-sulfamethazine on clinical 
warfarin poisoning 
The number of swine, experimental design, clinical effects, necropsy 
findings, and hematologic parameters were similar to Trial 4. However, 
litter control was not obtained, so these 16 animals were selected at ran­
dom from a large group of recently weaned pigs. 
Fifty milligrams of 1 percent warfarin was mixed in each pound of feed. 
This permitted a warfarin concentration of 0.5 mg/lb of feed. Pigs were 
fed at 5 percent of body weight giving a resultant dose of 0.025 mg/lb war­
farin daily to esch aniir.ai. Pigs in each pen were divided from one another 
when feeding was carried out. At intervals of 3 days, the weight and 
appropriate feed allotment were redetermined. 
Trial The effect of injectable sulfamethazine on warfarin poisoning 
Clinical and necropsy procedures were similar to Trials 3, 4, and 5. 
OSPT was used as the indicator of changes in the coagulation system. Oxa-
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lated plasma saved for determination of warfarin levels was frozen and 
stored at -20° C. 
Swine were dosed individually with the appropriate 0.025 mg/lb level 
of warfarin. Blood samples for warfarin and OSPT determinations were drawn 
pre-trial and at days 5, 7, 9, 12, 14, 16, 19, 21, and 26 of the trial. 
Sulfamethazine sodium^ at 250 mg/ml was administered parenterally to 
4 of the 8 pigs fed warfarin. Each pig received 25 mg/lb body weight of 
sulfamethazine sodium. Administration of sulfamethazine was begun 5 days 
prior to warfarin feeding and was continued for 26 days. Warfarin adminis­
tration began day 5 of the trial and was terminated at day 19. 
Trial The effect of sulfamethazine on plasma levels of warfarir. 
Two swine were fed a single dose of warfarin at 1.25 mg/lb body 
weight. This high dose was chosen in order to assume analytical detection 
of warfarin in plasma and to permit quantitative measurement of the 
decrease in plasma warfarin with time. One of these swine was given daily 
injections of sulfamethazine sodium at 25 mg/lb body weight for 5 days 
prior to and throughout the trial. Blood samples were drawn before and at 
0.5, 1.5, 2.5, and 4.5 days after warfarin administration. Plasma samples 
were examined for OSPT and for quantitative presence of warfarin. 
Estimation of Plasma Warfarin 
Four ml portions of exalated plasma were extracted with 20 ml 
2 
1,2-ethylene dichloride (EDC) according to the procedure described by 
Welling et al. (1970). The EDC was separated by centrifugation at 200 rpm 
1 [%) 
Sulmet , American Cyanamid, Princeton, N.J. 08540. 
2 
Eastman Organic Chemicals, Rochester, N.Y. 14650. 
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for 20 minutes. The amount of EDC recovered was measured and that quantity 
evaporated to dryness with nitrogen. The sides of the container were 
rinsed with acetone and dried with nitrogen. The residue was dissolved in 
acetone and spotted for thin-layer chromatography as outlined by Lewis 
ejt (1970). The locus of blue fluorescence for warfarin was marked and 
the spot cut out and immersed in 2 ml acetone for 20 minutes. The concen­
tration of warfarin was determined fluorometrically^ as described by Lewis 
et al. (1970). 
The calculation of warfarin concentration in plasma was as follows; 
. sample A fluorescence - blank A fluorescence gg warfarin _ warfarin 
standard fluorescence - blank fluorescence ml standard ^ 
2 ug warfarin _ ug warfarin 
ml plasma X ml EDC used ml plasma 
20 ml 
Change in fluorescence after acidification of the sample is signified by 
the symbol û fluorescence. Results calculated were plotted versus time. 
^Aminco-Bowman Spectrophotofluorometer, American Instrument Company, 
Inc., Silver Spring, Md, 
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RESULTS 
Clinical Signs and Gross Lesions in Swine Fed Warfarin 
Clinical signs associated with warfarin poisoning were observed in 
Trials 1, 2, 4, 5, 6, and 7. The clinical signs in warfarin-poisoned swine 
were lethargy, lameness, subcutaneous swellings, soft fluctuating articular 
enlargements, epistaxis, melena, ocular and auricular hemorrhage, recum­
bency, anemia, and sudden death. The number and degree of clinical signs 
varied slightly in the various trials. 
Trial I 
The effects in swine of different levels of warfarin is summarized in 
Table 1. The term traumatic hemorrhage refers to ocular hemorrhage as a 
result of the bleeding technique employed. Traumatic hemorrhage was also 
observed in the ear where metal identification tags had been placed. Dried 
and fresh blood covered the facial and lateral cervical areas of affected 
pigs. These swine consumed water frequently, and vater in the drinking 
pans became blood tinged. The sclera of affected pigs became extremely 
pale, and the skin of white animals lost the normal pink color. 
Hematomata, articular swellings, epistaxis, and melena were observed. 
A wide range of clinical signs including lameness, stiffness, lethargy, 
recumbency, dark tarry feces, and anorexia was noted in these pigs. 
Only one animal recovered after being clinically affected by spontane­
ous bleeding. One pig at the 0.05 mg/lb level of warfarin appeared to be 
recovering from clinical hemorrhage but died suddenly. Pulmonary edema was 
observed at necropsy. Both hemolytic and smooth colony types of Escherichia 
Table 1. Clinical response of swine to various levels of warfarin 
Warfarin 
dose 
Days on trial 
number mg/lb 1 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1251 0.05 0^ 0 0 h^ h 0 h 0 h H" He H d^ 
1256 0.05 0 0 0 h h h h H 0 0 
1252 0.10 0 0 0 H H d 
1257 0.10 0 0 0 H H H D 
1253 0.15 0 D 
0 1258 0.15 0 0 0 H H H H h 0 0 0 0 0 0 0 
1254 0.20 0 0 H D 
1255 0.30 0 0 H H d 
1260 0.50 0 0 H H hf H D 
1259 0.00 0 0 0 0 0 0 0 0 0 0 0 H h D 
^o clinical signs of hemorrhage. 
^Traumatic hemorrhage. 
^Spontaneous hemorrhage. 
^Euthanasia due to severe hemorrhage 
Death. 
w 
^Began administration of warfarin at 0.025 mg/lb body weight. 
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coli were isolated from the intestine, and a diagnosis of edema disease was 
made. 
Pig 9 was changed from the control diet to one of warfarin at 0.025 
mg/lb body weight on day 7 of the trial. After 8 days at that level of 
warfarin, lameness occurred in the left pelvic limb, and the animal died 
after 10 days of warfarin administration. 
Lesions of warfarin poisoning were found in 8 of 10 swine in Trial 1. 
Pigs 6 and 8 did not have gross lesions of hemorrhage. The type and dis­
tribution of lesions found in 8 swine with warfarin poisoning are sum­
marized in Table 2. The most frequent lesions were anemia, hematomata, and 
articular hemorrhage. 
Trial 2 
Of 4 pigs given warfarin at 0.0075 mg/lb body weight and 0.0125 mg/lb 
body weight, none had clinical signs or lesions of warfarin poisoning. One 
pig developed diarrhea on day 12 of the trial, and this persisted through­
out the experiment. Gross lesions of hemorrhage were not found in swine 
from Trial 2. 
Trial 3 
Pigs in this trial received warfarin at 0.0075 mg/lb and levels of 
tylosin and sulfamethazine as high as 1000 and 300 grams per ton of feed, 
respectively. Neither clinical signs nor lesions of warfarin poisoning 
developed during the 21 days of the experiment nor during the 7-day obser­
vation period after drugs were withdrawn. Appetite and general appearance 
were good. One pig from each of the 8 litters was necropsied, and no gross 
lesions were detected. 
Table 2. Gross lesions in swine fed various levels of warfarin 
Gross les ions 
Intra­ Hemorrhage 
Warfarin Colonic muscular Ocular CNS in 
Pig dose in hemor­ hemor­ Hema- hemor­ hemor­ Hemo- other 
number mg/lb Anemia rhage rhage tomata rhage rhage arthrosis areas 
1259 0.025 -H-
1251 0.050 +++ ++ 
1252 0.100 •H" +++ + 
1257 0.100 +++ ++ -H-t- + 
1253 0.150 +++ +++ +++ -H-
1254 0,200 ++ •H" -H-f- -H- + 
1255 0.300 ++ +++ +4- + 
1256 0.500 -t-f + ++ 
^Marked. 
^Severe. 
^Moderate. 
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Trial 4 
The clinical signs in swine given warfarin at 0.025 mg/lb body weight 
are presented in Table 3. In the treatment group with tylosin-sulfametha-
zine added, no clinical signs or deaths were noted during a 20-day observa­
tion period, while all swine in the control (warfarin only) group had died 
by day 14. Spontaneous hemorrhage was observed in a majority of the con­
trol pigs. Four swine from the tylosin-sulfamethazine group were necrop-
sied, and mild lesions of hematomata were found in two pigs. The type and 
degree of hemorrhagic lesions found in Trial 4 are recorded in Table 4. 
Trial 2 
No adverse clinical signs were observed in swine fed tylosin-sulfa­
methazine in combination with warfarin. Of pigs fed warfarin alone, two 
had died of hemorrhage by day 17 while the remainder of the group was free 
of clinical signs throughout the 23-day observation period. Please note 
Table 4. 
Trial 6 
Four of the 8 swine receiving warfarin were injected with sulfametha­
zine sodium ar 25 mg/lb. All swine given only warfarin had hemorrhagic 
lesions, and 3 of these 4 pigs died. Only 1 of the 4 pigs injected with 
sulfamethazine was affected with hemorrhages. The type and degree of clin­
ical signs observed are summarized in Table 5. 
Table 3, Clinical signs in swine fed warfarin at 0.025 mg/lb in presence or absence of antibacterial 
combination^ 
Days on trial 
Treatment number 5 6 7 H 9 10 11 12 13 14 15 16 17 18 19 
Antibacterial 751 o" 0 0 0 0 0 0 0 0 0 0 0 0 H 
752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
No 759 0 0 0 
Antibacterial 760 0 0 0 0 0 h® h h h D 
761 H H H (i 
762 D 
763 0 0 0 0 0 H H H H D 
764 0 H H H H H H D 
765 H H h H H H 
766 0 0 0 0 0 h d^ 
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^Tylosin phosphate, 1000 grams/ton feed and sulfamethazine sodium, 300 grams/ton feed, 
^No clinical signs of hemorrhage. 
^Spontaneous hemorrhage. 
^Death. 
^Traumatic hemorrhage. 
^Euthanasia due to severe hemorrhage. 
0 
0 
Table 4. Gross lesioni; In swine fed warfarin at 0.025 mg/lb in presence or absence of an antibacte­
rial 
Intra-
Colonic muscular Ocular Hem- Thoracic CNS 
Pij5 hemor­ Hema- hemor- hemor­ arthro- hemor- hemor­ Epis-
Treatment numlier Anemia rhage toma rhage rhage sis rhage rhage taxls 
Trial 4 759 
(No 7(50 4- ' 444- 44- 44- 44-
antibacterial) 7(31 + 44- 44- H- 4-
7(52 + 44- 44-f 44-
7(53 ++ +44- -H-
7(54 ++ 4- 444- 44-
7(55 ++ 4-44- 4-
7(56 44- 1 1 1 -H- 4-
Trial 5 1608 44- 444- 4-
(No 1613 44- 4-h 4-
antibacterial) 
Trial 6 1681 44 -i- -h 4-
(No 1684 44- 444- 4-
antibacterial) 1686 44- + 
Trial 6 1687 444- 4- 4-
(Antibacterial 
present)^ 
^Marked. 
Massive. 
^Moderate. 
Sulfamethazine sodium, parenteral at 25 mg/lb body weight. 
Table 5, Clinical signs in swine fed warfarin at 0.025 mg/lb in presence or absence of parenteral 
sulfamethazine sodium 
Days on trial 
Treatment number 0 5« 14 15 16 17 18 19b 20 21 23 26 33 
Sulfamethazine 1682 o' 0 h' 0 0 0 0 0 0 0 0 0 0 
25 mg/lb/day 1683 0 0 0 0 0 0 0 0 0 0 0 0 0 
1685 0 0 0 0 0 0 0 0 0 0 0 0 
1687 0 0 h h d® 
No 1681 0 0 H D® 
Sulfamethazine 1684 0 0 h h h h h h D 
1686 0 0 h h h D 
1688 0 0 h h h h h h 0 0 • 0 0 0 
^Initiation of feeding warfarin at 0.025 mg/lb body weight. 
Cessation of feeding warfarin. 
^No clinical signs of hemorrhage. 
^Traumatic hemorrhage. 
^Euthanasia due to severe hemorrhage 
^Spontaneous hemorrhage. 
®Death. 
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Trial 7. 
On the fourth day after receiving 1.25 mg/lb warfarin, the control pig 
died from hemorrhage caused by coagulation failure- The pig given sulfa­
methazine survived a similar warfarin dose with no ill effects. 
Survival Rate and Scope of Lesions 
in Warfarin-Poisoned Swine 
The number of swine that had survived to days 7, 14, and 21 in all 
trials where warfarin at 0.025 mg/lb was administered either alone or in 
conjunction with tylosin-sulfamethazine combination can be found in Fig­
ure 1. 
The incidence and type of lesions in 14 swine dead from warfarin poi­
soning are summarized in Figure 2. The occurrence of lesions in decreasing 
order of frequency were anemia, colonic hemorrhage, subcutaneous hema-
tomata, intramuscular hemorrhage, ocular hemorrhage, hemarthrosis, intra­
thoracic hemorrhage, CNS hemorrhage, epistaxis, and hemorrhage in other 
Gross and Microscopic Lesions 
in Warfarin-Poisoned Swine 
Anemia in affected pigs apparently was caused by hemorrhage. Impor­
tant sites of blood loss were from the eye and colon and into subcutaneous 
or intermuscular spaces. No gross inflammatory reaction was observed in 
the colon, periorbital tissue, or subcutaneous spaces. 
Contents of the colon and ileum were often dark brown to black, tarry, 
and foul smelling. This characteristic colonic hemorrhage is seen in Fig­
ure 3. 
Figure 1. Number of swine surviving warfarin administration (0.025 mg/lb) when tylosin-sulfametha-
zine was prosent or absent in the diet 
01 WARFARIN AMD TYLOSIN-SULFAMETHAZINE COMBINATION 
QCONTROL (WARFARIN ONLY) 
DAYS ON WARFARIN 
Figure 2. Incidence of specific hemorrhagic lesions in 14 swine dying from warfarin poisoning 
SWINE AFFECTED FROM AMONG 14 EXAMINED 
zv 
Figure 3. Marked colonic hemorrhage, blood-stained feces, lesser omental 
hemorrhage, and generalized anemia characteristic of swine with 
experimental warfarin toxicosis. The warfarin dosage was 0.20 
mg/lb body weight 
Figure A, Subcutaneous and intermuscular hemorrhages in a pig fed warfarin 
at 0.10 mg/lb body weight 
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The intermuscular and subcutaneous hemorrhages were interspersed with 
small to moderate amounts of edema. Hemorrhages tended to follow along 
fascial planes and between major muscle bundles. Most frequent locations 
for hemorrhages were the submandibular area, subcutaneous inguinal area, 
and intermuscular spaces between the semitendinosus, semimembranosus, and 
gracilis muscles. Distribution of subcutaneous and muscular lesions may be 
found in Figures 4 and 5. 
Hemorrhage in the subcutaneous periarticular tissue caused swelling 
around the tarsal-metatarsal articulations. Bleeding into the articular 
capsule and collection of free, unclotted blood in the articular space were 
observed. 
Hemorrhage in the central nervous system (CNS) was subdural in nature 
over the parietal and occipital lobes of the cerebrum, cerebellum, and 
cervical spinal cord. Hemorrhage into CNS parenchyma was not observed. 
The gross lesion of cerebellar meningeal hemorrhage is shown in Figure 6. 
Tissues of warfarin-poisoned swine were examined microscopically for 
cellular and vascular changes. No evidence of a primary lesion due to 
warfarin was found by light microscopy. Mild centrolobular hepatic fatty 
change and passive congestion were occasionally observed. Degenerative or 
inflammatory vascular lesions in hemorrhagic areas were not found. Inter­
muscular edema and hemorrhage were observed microscopically. 
Blood Coagulation Activity in Warfarin-Poisoned Swins 
Affected swine had large and consistent changes in parameters of the 
coagulation system. Increases in clotting time, OSPT, and APTT were 
observed. 
Figure 5. Large periarticular hematomata in a pig given at 0.025 mg/lb 
body weight 
Figure 6. Ksr.crrhages in cerebellar subdural and arachnoid spaces in a pig 
with warfarin poisoning. The warfarin dosage was 0.10 mg/lb 
body weight 

48 
Trial 1 
Results of clotting time, OSPT, and APTT are presented in Table 6 for 
pre-trial samples and for days 3, 6, and 9. Data presented are individual 
values where one animal was used or mean values when two animals were used. 
Figures 7,8, and 9 depict mean values of clotting time, OSPT, and APTT, 
respectively, for pre-trial, three-day, and six-day samples. Coagulation 
activity times increased in approximately linear manner at day 6 for dos­
ages of warfarin from 0.0125 mg/lb to 0.150 mg/lb. Small increases in OSPT 
and APTT were observed at most dosages when pre-trial values were compared 
to day 3 values. 
Trial 2 
Coagulation activity is included in Figures 7, 8, and 9 for blood sam­
ples from days 0, 3, and 6. 
Trial 3 
Mean values for clotting time. OSFT. and APTT are presented in Figures 
10, 11, and 12. No animals were lost in this trial, so means represent a 
full complement of data. Marked differences in treatment means were not 
observed. Clotting time was elevated slightly at day 7 and then declined 
toward pre-trial levels. OSPT values followed a similar pattern of slight 
early rise followed by a decline. APTT values were erratic, and no trend 
could be detected. 
Trial 4 
Mean values for clotting time, OSPT, and APTT are presented in Figures 
13, 14, and 15, respectively. Large and consistent rises occurred in these 
Table 6. Blood coagulation parameters in swine fed warfarin 
Pig 
num­
ber 
Warfarin 
dose 
in 
mg/lb Clot 
5 c 
OSPT APTT 
Days on trial 
Clot OSPT APTT Clot OSPT APTT Clot OSPT APTT 
1251 0.05 1.5 13.4 34.0 3.5 12.7 39.8 4.5 28.9 78.8 5.5 47.4 150. 0 
1252 0.10 1.5 12.4 29.1 3.0 10.8 37.4 19.5 63.7 152.7 
1253 0.15 1.0 12.3 32,4 4.0 12.2 49.9 17.5 68.9 165.7 
1254 0.20 0.5 12.1 33.7 1.0 11,1 43.1 26.0 150.0 240.9 
1255 0.30 1.0 11.5 32.9 3.5 11.5 53,2 42.5 248.5 580.6 
1256 0.05 1.0 12.8 37.1 2.5 12,3 61.2 12.5 34.0 172.2 9.0 81.1 150. 0 
1257 0.10 1.5 12.1 34.7 3.5 12.2 55.5 11.5 61.4 242.0 
1258 0.15 2.0 10.8 28.1 4.5 11,5 50.8 16.0 72,7 340.3 
1259 0.00 1.0 12,6 35.2 4.5 11.9 41.7 2.5 11.9 43.1 2.0 12.9 44. 3 
1260 0.50 1.0 12.0 39.1 4.0 11.9 53.7 32.5 211.9 360.0 
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Figure 7. Clotting time for swine fed graded doses of warfarin 
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Figure 8. One-Stage Prothrombin Time in swine fed graded doses of warfarin 
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Figure 9. Activated Partial Thromboplastin Time in swine fed graded doses 
of warfarin 
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Figure 10. Mean clotting times for 32 swine fed tylosin-sulfamethazine combination with or without 
warfarin. The warfarin dosajjo was 0.0075 mg/lb body weight 
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Figure 11. Mean One-Stage Prothrombin Times for 32 swine fed tylosin-sulfamethazine combination with 
or without: warfarin. The warfarin dose was 0.0075 mg/lb body weight 
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Figure 12. Mean Activated Partial Thromboplastin Time for 32 swine fed 
tylosin-sulfamethazine combination with or without warfarin. 
The warfarin dose was 0.0075 mg/lb body weight 
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Figure 13. Mean clotting time for 16 swine fed warfarin with or without 
tylosin-sulfamethazine combination. The warfarin dosage was 
0.025 mg/lb body weight 
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Figure 14. Mean One-Stage Prothrombin Times for 16 swine fed warfarin with 
or without tylosin-sulfamethazine combination. The warfarin 
dosage was 0.025 mg/lb body weight 
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Figure 15. Mean Activated Partial Thromboplastin Time for 16 swine fed 
warfarin with or without tylosin-sulfamethazine combination. 
The warfarin dosage was 0.025 mg/lb body weight 
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parameters for the group receiving warfarin only. The rise in coagulation 
activity values was slower and of lesser magnitude in swine receiving 
tylosin-sulfamethazine in combination with warfarin. 
Trial 2 
Mean clotting and prothrombin times are plotted in Figures 16 and 17. 
Marked divergence in these values was observed, with the control (warfarin 
only) group having consistently higher values. During this trial, values 
for both treatments rose and then began to fall toward normal. 
Trial Ô 
Mean OSPT values are shown in Figure 18 for swine receiving warfarin 
with parenteral sulfamethazine as well as those receiving only warfarin. 
There was marked elevation of OSPT in warfarin treated pigs when compared 
to those swine given warfarin with sulfamethazine. Upon withdrawal of war­
farin, OSPT returned promptly to normal in both groups. One pig remained 
alive in the control group versus 3 pigs in the sulfamethazine group-
Trial 7 
Prothrombin times are depicted in Figure 19 for each of 2 pigs fed a 
single dose of warfarin at 1.25 mg/lb body weight. The pig given warfarin 
without previous and concurrent exposure to parenteral sulfamethazine 
developed a markedly prolonged OSPT. 
Hematologic Changes 
Several hematologic parameters related to blood coagulation were eval­
uated. These included total protein, fibrinogen, packed cell volume, dif­
ferential leukocyte count, and clot retraction. "Hie results of hematologic 
Figure 16. Mean clotting time for 16 swine fed warfarin with or without 
tylosin-sulfamethazine combination. The warfarin dosage was 
0.025 mg/lb body weight 
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Figure 17. Mean One-Stage Prothrombin Time for 16 swine fed warfarin with 
or without tylosin-sulfanethazine combination. The warfarin 
dosage was 0.025 mg/lb body weight 
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Figure 18. Mean One-Stage Prothrombin Time for 8 swine fed warfarin with 
or without parenteral sulfamethazine. The warfarin dosage was 
0.025 mg/lb body weight 
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Figure 19. One-Stage Prothrombin Time for 2 swine fed warfarin with or 
without parenteral sulfamethazine. The warfarin dosage was 
1.25 mg/lb body weight 
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studies in Trials 3 and 4 are shown in Tables 7 and 8 expressed as treat­
ment means. 
Trends away from control values were not observed for fibrinogen and 
total protein. A slight deviation in packed cell volume was noted in 
Trial 3. This change was not statistically significant. All blood samples 
had good clot retraction at 2 and 24 hours after coagulation occurred. 
Total protein and fibrinogen values were not depressed in any pigs. Based 
on data from these trials, the above parameters were not evaluated in sub­
sequent trials. 
Coagulation Factor Correction Studies 
Plasma samples with prolonged OSPT and APTT from Trial 1 and Trial 4 
were treated with both aged serum and adsorbed plasma. In every case, OSPT 
and APTT were corrected by addition of serum but not by adsorbed plasma. 
This was interpreted as deficiency of factors II, VII, IX, and X in war­
farin-treated swine. 
Statistical Treatment of Coagulation Activity Values 
Tests of significance utilizing analysis of variance were conducted on 
coagulation data from Trials 3, 4, 5, and 6. Overall means, treatment 
means, and day means were computed for clotting time, OSPT, APTT, and PCV. 
In Table 9 and 10, the statistical significance of parassstsrs measured 
in antibacterial and warfarin trials is summarized. Table 11 compares cor­
relation coefficients and their significance for Trials 3, 4, and 5. 
Analysis of variance for Trial 3 was completed with no missing data. 
Results are presented in Table 9 for clotting time, OSPT, and APTT. F-
Table 7. Mean hematologic values for swine fed warfarin and antibacterial at two levels 
Treatment 
Low ^ High ^ Low High 
antibacterial antibacterial antibacterial antibacterial 
without without with with 
warfarin warfarin warfarin warfarin 
DfiY Day Day Day 
Cells counted 0 14 0 14 0 14 0 14 
Segmented neutrophils (%) 17 28 23 27 24 34 29 30 
Band neutrophils (%) 4671537
Lymphocytes (%) 77 66 69 64 72 58 66 70 
Monocytes (%) 20100000
Basophils (%) 0 0 0 0 1 0 0 0 
Eosinophils (%) 22121221
Nucleated erythrocytes (%) 0 1  
Packed cell volume (%) 36 37 36 36 36 38 37 36 
^Tylosin phosphate, 100 gni/ton feed and sulfamethazine sodluin, 100 gm/ton feed. 
^Tylosin phosphate, 1000 gm/ton feed and sulfamethazine sodium, 300 gm/ton feed. 
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Table 8. Mean hematologic values for swine fed warfarin with or without 
antibacterial 
Treatment 
Antibacterial 
and warfarin Warfarin only 
Day Day 
Cells counted 0 7 0 7 
Segmented Neutrophils (%) 29 26 28 28 
Band Neutrophils (%) 4 5 6 8 
Lymphocytes (%) 65 67 64 63 
Monocytes (%) 0 0 0 0 
Basophils (%) 0 0 0 0 
Eosinophils (%) 2 2 2 1 
Nucleated Erythrocytes (%) 3 2 2 1 
Packed Cell Volume (%) 31 33 31 31 
^Tylosin phosphate, 1000 gm/ton feed and sulfamethazine sodium, 300 
gm/ton feed. 
values were regarded as significant (P<.05) according to the appropriate 
table in Snedecor and Cochrane (1967). 
Results of analysis of variance for clotting tise, OSPT, and APTT in 
Trials 4 and 5 are presented in Table 10. Results are based on a weighted 
analysis computed to account for missing data caused by death of experimen­
tal swine. 
Correlations between clotting time and OSPT, clotting time and APTT, 
and OSPT and APTT were computed and the results summarized in Table 11. 
Correlation coefficients for other parameters are included in Table 11. 
Plasma Warfarin Levels in Control 
and Sulfamethazine Treated Swine 
Results of analysis for plasma warfarin in 2 swine fed equal doses 
of warfarin on a body weight basis are plotted in Figure 20. The sulfa-
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Table 9. Statistical significance of calculated F-values for swine fed 
warfarin or tylosin-sulfamethazine antibacterial 
Degrees F-value for each variable T • o 
Source freedom Clot* OSPT APTT 
Warfarin l", 6^ 13.28* 13.57* 3.86 
Antibacterial 1, 6 12.68* 1.06 0.00 
Antibacterial X Warfarin 1, 6 10.30* 0.02 0.00 
Day 1, 6 13.29* 4.37 1.60 
Warfarin X Day 1, 6 12.05* 4.33 5.18 
Antibacterial X Day 1, 6 7.34* 5.63 7.35* 
Antibacterial X Warfarin X Day 1, 6 7.28* 8.94* 5.62 
^Clotting Time. 
b 
One-Stage Prothrombin Time. 
^Activated Partial Thromboplastin Time. 
'^Numerator. 
e 
Denominator. 
•Significant at P<0.05. 
methazine-free pig developed higher plasma warfarin levels, reached a 
greater peak of warfarin concentration, and maintained a more elevated 
plasma warfarin level than did the pig pre-treated with parenteral sulfa­
methazine . 
81 
Table 10. Statistical significance of calculated F-values for parameters 
studied in swine fed warfarin with or without tylosin-sulfa-
methazine antibacterial 
Trial Degrees F-value for each variable 
Source number freedom Clot OSPT APTT 
Antibacterial 4 11.74* 25.66* 63.27** 
5 1, 6 14.88** 141.11** - — 
Day 4 2, 12 89.87** 41.86** 33.79** 
5 1, 6 14.45** 22.12** 
Antibiotic X Day 4 2, 12 30.70** 22.50** 20.23** 
5 7, 6 11.87** 17.84** 
Denominator. 
•Significant at P<0.05. 
••Significant at P<0.01. 
Table 11. Correlation coefficients for parameters studied in swine fed warfarin and tylosin-sulfa 
methazine antibacterial 
Variable 
Variable 
Clotting time 
Prothrombin 
time 
Partial 
thrombo-plastin 
time 
Total 
protein 
Fibrinogen 
Packed cell 
volume 
Clotting 
time 
1.000 
1.000 
1.000 
0.153 
0.744** 
0.622** 
•0.074 
0.875** 
0.725** 
0.298** 
0.353** 
0.157 
-0.842** 
^96 degrees freedom. 
^65 degrees freedom. 
^53 degrees freedom. 
*Significant at P<0.05. 
**Significant at P<0.01. 
Pro­
thrombin 
time 
1.000 
1.000 
1.000 
0.069 
0.922** 
0.72:3** 
-0.016 
•0.056 
•0.016 
•0.697** 
Partial 
thrombo­
plastin time 
Total 
protein 
Fibri­
nogen 
Packed 
cell 
volume 
1.000 
1.000 
1.000 
0.042 
0.061 
0.236* 
-0.820** 
1.000 
0.537** 
0.186 
1.000 
0.090 1.000 
Trial 
number 
.a 
3 
4 
5 
3 
4 
5 
3 
4 
5 
3 
4 
5 
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Figure 20. Warfarin concentration in plasma of two swine fed warfarin with 
or without parenteral sulfamethazine. The warfarin dosage was 
1,25 mg/lb body weight 
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DISCUSSION 
Clinical Response 
The clinical response of swine to graded doses of warfarin in Trial 1 
varied with the amount of drug consumed. While the trend is not strictly 
linear, there is a direct response to amount of warfarin administered. 
McGirr and Papworth (1955) demonstrated that swine fed warfarin at various 
doses tended to respond in 1 of 2 ways. Either there was a gradual onset 
of bleeding and hematomata or there was massive hemorrhage with associated 
acute death. Frazier (1966) reported swine accidentally poisoned by war­
farin were affected by lameness and fecal hemorrhage but had near-normal 
appetites. Of the vitamin K-deficient swine studied by Schendel and 
Johnson (1962), acute onset and death from hemorrhage, as well as hemor­
rhage with recovery, were observed. Osweiler £t (1970), in describing 
vitamin K-responsive bleeding in swine, included clinical histories of both 
chronic and acute hemorrhage. 
Koch-Weser and Sellers (1971a), Rowsell (1968), and Deykin (1970a) 
reported that warfarin poisoning and vitamin K deficiency cause a similar 
depression in coagulation factors. Thus, the basis for the clinical course 
of warfarin poisoning, vitamin K deficiency, and porcine hemorrhagic dis­
ease appears similar. 
The onset of clinical bleeding, especially ocular, subcutaneous, and 
intermuscular bleeding, was exacerbated by handling swine during blood 
sampling and weighing. Hemorrhage found at the sites of puncture by iden­
tification eartags was considered due to trauma. Although articular 
hemorrhages and hematomata were regarded as spontaneous, they were probably 
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initiated by trauma from articular movement or reaching over feeding pans. 
Signs of central nervous dysfunction seen in 2 swine were associated with 
diffuse subdural hemorrhage found at necropsy. 
Lesions 
Pale red blood of watery consistency was a characteristic lesion in 
warfarin-poisoned swine. No attempt was made to classify the type of 
anemia since acute blood loss appeared to be the cause. Furthermore, 
erythropoetic activity appeared normal as indicated by results of differen­
tial leukocyte counts and presence of nucleated erythrocytes and adequate 
platelet numbers. Hematomata were found in various parts of the body, par­
ticularly in areas of stress such as submandibular, lateral cervical, 
inguinal, and periarticular regions. These areas were most often in con­
tact with feeding pans, concrete floors, and sidewalls of pens. 
While the primary lesion observed was hemorrhage, edema was occasion­
ally present. This could be caused by slowing and stagnation of blood flow 
through a hemorrhagic area or by blockage of lymphatics with erythrocytes. 
Extravasated blood was often coagulated when hemorrhage was located in 
the subcutaneous or intermuscular spaces. Tissue damage caused by cellular 
anoxia may occur as a result of hemorrhage. Rowsell (1968) reported that 
Thromboplastin (Factor III) released from damaged tissues could initiate a 
more rapid coagulation. 
No gross or microscopic lesions were found associated with colonic 
hemorrhage in experimental swine. Bleeding could result from peristaltic 
activity of the intestine and colon in a manner similar to the increased 
movement and resultant hemorrhage observed around joints. Ultrastructural 
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changes in capillary endothelium of rats treated with toxic doses of war­
farin have been reported by Kahn et al. (1971). These changes were loss of 
ground substance and decreased organelle content. However, warfarin-
induced capillary damage observed by light microscopy has not been reported. 
The hemorrhagic lesions in warfarin poisoning have not been associated 
with decreased numbers of thrombocytes nor a decline in the levels of total 
protein and/or fibrinogen. Levine (1970) indicated a decrease in platelet 
adhesiveness which may be causative of minute capillary hemorrhages during 
warfarin poisoning. 
The type and pattern of hemorrhage in affected swine could not be cor­
related with the amount of warfarin ingested nor the number of days for . 
which the warfarin had been fed. The onset of hemorrhagic lesions and 
clinical signs appear more dependent upon the nature of traumatic or envi­
ronmental conditions which initiate hemorrhage in a susceptible animal than 
upon total dosage. 
Comparison of Tables 1 and 6 reveals that swine having prothrombin 
times on day 6 of less than 34 seconds did not exhibit spontaneous hemor­
rhage on that day. However, swine having 28.9-second and 34.0-second pro­
thrombin times did have hemorrhage in response to the trauma of ocular 
bleeding. Further examination of Tables 1 and 6 reveals the day 12 values 
of prothrombin time for pigs 1258 and 1259 to be 19.9 and 16.4 seconds, 
respectively, at which time no hemorrhagic manifestations were noted. Com­
parison of Table 3 with Figure 14 discloses that on day 3 of Trial 4, the 
control (warfarin only) group swine had a mean prothrombin time of 25.5 
seconds, but there was no associated clinical hemorrhage. The prothrombin 
time range in this group was from 18.1 seconds to 35.4 seconds. By day 5 
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of the trial, 3 swine in the control group had developed spontaneous hemor­
rhage or had died as a result of hemorrhage. These pigs had prothrombin 
times of 30.3 seconds, 33.4 seconds, and 42.4 seconds. Other swine in the 
group had prothrombin times as high as 51.9 seconds with no clinical evi­
dence of hemorrhage. 
From the clinical data relative to warfarin administration, it appears 
that approximately 5 days is needed after the administration of warfarin 
for clinical signs to appear. Langdell (1969) reported on the half-life of 
plasma coagulation factors depressed in man by warfarin administration. 
Factors II, VII, IX, and X have half-lives in man of 100 hours, 5 hours, 
20-30 hours, and 20-30 hours, respectively. Deykin (1970a) stated that at 
chronic low doses, warfarin does not completely suppress procoagulant syn­
thesis. Thus, the effect of low doses of warfarin depends on a balance 
between the rate of intake and the rate of degradation and excretion of 
warfarin. Nagashima e_t al. (1969) found that in most individuals the 
depression of production of Factors IÎ, Vil, IX, and X is a logrithmic 
function of plasma warfarin concentration. Since the acquired coagulation 
deficiency in warfarin poisoning is a multiple one, the clinical result 
will depend upon the relative rates of disappearance of each of the coagu­
lation factors and upon the total effect of loss of these factors from the 
coagulation scheme. 
The clinical response of swine to experimental warfarin administration 
was similar to the signs reported by Frazier (1966), McGirr and Papworth 
(1955), and Reihart and Reihart (1952) for uncomplicated warfarin poison­
ing. Results of primary clinical vitamin K deficiency in swine were not 
available for comparison. However, experimentally induced vitamin K defi­
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ciency reported by Schcndel and Johnson (1962) involved similar hemorrhagic 
lesions. Osweiler e_t (1970) and Fritschen et al. (1970) Indicated that 
a vitamin K-responsive hemorrhagic disease of swine involved lesions simi­
lar to those reported for warfarin poisoning. No difference was detected 
between the lesions and signs reported for warfarin toxicosis and vitamin K 
deficiency. 
Coagulation Factor Changes 
Warfarin produced consistent changes in clotting time, OSPT, and APTT. 
This effect was exacerbated, both by increased dosage of warfarin (Trial 1) 
and by continued daily administration (Trials 4, 5, 6). Nagashima and Levy 
(1969) reported that the plasma half-life of warfarin in several species 
varied from 9.4 to 10.4 hours for the rat, 22 to 23 hours for the dog, and 
29 to 43 hours for man. Furthermore, they determined that the effect of 
dosage varied with species. Their dogs had a plasma warfarin half-life 
independent of dosage while half-life declined slightly with increasing 
dosage in the rat but increased markedly with increasing dosage in the mon­
key. Although specific warfarin half-life studies have not been reported 
for swine, it would seem that an appropriate half-life in swine was allow­
ing larger experimental doses of 0.025 mg/lb to accumulate while the smal­
ler 0.0075 mg/lb doses used in Trial 3 were excreted at a rate approxi­
mately equaling or exceeding intake. 
The parameters chosen for assessing clotting function were selected on 
the basis of availability of instrumentation, applicability of the tech­
nique, and suitability to assess the coagulation factors most affected by 
warfarin and vitamin K. Rowsell (1968) reported that the coagulation fac­
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tor activity of swine is identical to that of man in standard test systems 
for Factors II, V, VII, and X. Porcine coagulation activity for Factor IX 
was slightly increased over man. For these reasons, commercial reagents 
were chosen for the tests employed giving the advantages of standardization 
and stability not found in prepared reagents. 
Deykin (1970a) and Sirridge (1967) reviewed the coagulation factors 
depressed during warfarin poisoning or vitamin K deficiency. They reported 
that depression of Factors II, VII, IX, and X was associated with both sit­
uations. Quick (1966) and Thomson (1970) listed the factors measured by 
OSPT as fibrinogen, Factor II, Factor V, Factor VII, and Factor X. These 
factors are part of the extrinsic system of the blood coagulation scheme as 
described by Langdell (1969). The APTT was recommended by Thomson (1970) 
to measure the intrinsic system of the coagulation scheme. The APTT meas­
ures deficiencies in Factors II, V, VIII, IX, X, XI, and XII. It is more 
sensitive to abnormalities occurring at early stages of coagulation leading 
up to prothrombin activation. However, a minor clotting factor deficiency 
may be masked and compensated for by an elevation of one or more of other 
factors. 
When the extrinsic system alone is deficient, a lack of Factor VII is 
most likely. If the APTT is prolonged in the presence of a normal OSPT, 
Factors VIII or IX are generally deficient. When both OSPT and APTT are 
increased, a multiple deficiency involving Factors II, V, VII, IX, or X is 
usually indicated. 
The preparation of barium sulfate adsorbed plasma described by 
Langdell (1969) results in plasma deficient in Factors II, VII, IX, and X 
but rich in Factor V and Factor VIII. Thomson (1970) lists the factors 
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present in aged serum to include Factors VII, IX, X, XI, and XII. Owen 
et al. (1969) have devised a method for estimation of factor deficiencies 
by addition of adsorbed plasma and aged serum to plasmas with prolonged 
OSPT. This has been expanded to include use of the APTT^ as follows: 
APTT OSPT 
Original time Plasma Serum Plasma Serum Deficiency 
APTT OSPT reagent reagent reagent reagent indicated 
A^ c'' NC^ 
__6 
— = VIII 
A N C C — - — XI, XII 
A N NC C - - — IX 
A A C NC C NC V 
A A NC C NC C X 
A A NC NC NC NC II 
N A — — — — NC C VII 
By the above scheme, a deficiency of Factors VII and X as well as 
probable deficiency in Factors II and IX was suspected in Trials 1 and 4. 
Hiis agrees with findings of Deykin (1970a), Sirridge (1967), and Owen 
et al. (1969) relative to warfarin therapy and vitamin K deficiency in man. 
No significant effect upon OSPT or APTT was found related to tylcsin-
sulfamethazine treatments used in Trial 3. A significant change in clot­
ting time was noted in Trial 3 for the tylosin-sulfamethazine treated swine. 
The change in clotting time was not in agreement with the insigificant 
^Dade Division, American Hospital Supply, Miami, Florida 33152. 
2 
Abnormal time. 
3 
Normal time. 
4 
Corrected time. 
^Not corrected time. 
^Not applicable. 
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changes reported for OSPT and APTT in the same trial- Nor is the change in 
clotting time observed on the high tylosin-sulfamethazine with warfarin 
treatment during days 7 and 14 of the trial associated with decreases in 
clot retraction or plasma fibrinogen level. Messersmith ^  al. (1967) 
studying combinations of sulfamethazine, aureomycin, and penicillin 
reported a decrease in clotting time with increased days on sulfamethazine. 
Some difficulties are encountered in the use of clotting time as a 
quantitative measure of the coagulation system. Rowsell (1968) suggested 
that tissue trauma with inclusion of Factor III in the sample would promote 
clotting at a more rapid rate. Didisheim et al. (1959) studied the coagu­
lation systems of several mammalian species and concluded that clotting 
time appeared quite dependent upon variations in technique. Experimental 
technique in Trial 3, including bleeding procedure and oxalate dilution, 
was investigated with no indication of technical or procedural variation. 
Neither available literature nor subsequent clotting time findings were 
suggestive of the mechanism for increased clotting time in Trial 3. 
A significant elevation in OSPT and APTT was observed for those swine 
fed warfarin at a level of 0.0075 mg/lb of body weight in Trial 3. This 
was the effect expected from warfarin fed at low levels. However, the 
times did not approach the levels of Trial 1 where clinical hemorrhage was 
produced. The results of Trial 3, when swine were fed 2 levels of tylosin-
sulfamethazine combination with or without warfarin, support the conclu­
sions of Griminger (1957), Udall (1965), Deykin (1970a), and Koch-Weser 
and Sellers (1971a) that in the presence of a normal diet, oral antibiot­
ics do not enhance or contribute to clinical hypoprothrombinemia. Further­
more, no evidence was found that 2 standard laboratory coagulation tests 
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were prolonged by antibiotic. If the increased clotting time of the group 
fed warfarin with high tylosin-sulfamethazine is considered in light of 
normal OSPT and APTT, then some nonvitamin K dependent clotting function 
may be involved. The marked and consistent changes in clotting time, OSPT, 
and APTT, seen in swine given only warfarin at 0.025 mg/lb, are evidence 
for a protective or competitive effect of tylosin-sulfamethazine against 
warfarin. 
Antibiotics or antibiotic combinations have not been previously 
reported as antagonistic to warfarin. Kabins (1972), Koch-Weser and 
Sellers (1971b), and Sher (1971) reported that drugs inhibiting the action 
of coumarins in man included barbiturates, glutethimide, griseofulvin, and 
heptabarbital. These drugs act either by enhancing coumarin metabolism or 
by inhibiting coumarin absorption. 
Robinson et^ al. (1971) reported that nonsystemic gastrointestinal 
drugs could interact with warfarin to form unabsorbable complexes. When 
warfarin ( K 5.6) entered the small intestine, it was raoidlv converted to 
p a ' ' • -
the anionic form which was bound to cholestyramine given orally. Koch-
Weser and Sellers (1971b) reported that cholestyramine binding of bile 
salts may lower the absorption of vitamin K and enhance coumarin action. 
Thus, the net effect of a drug such as cholestyramine must be elevated rel­
ative to both warfarin binding and vitamin K absorption. 
In Trial 6, warfarin was administered orally with or without the con­
comitant parenteral administration of sulfamethazine. The results indicate 
that the anti-hypoprothrombinemic effect observed from the oral tylosin-
sulfamethazine combination was also seen when sulfamethazine was given 
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parenterally. This would suggest that an intestinal antibacterial-warfarin 
complex is not involved in the antagonistic mechanism. 
Stowe (1965) reported that sulfonamides are bound to plasma albumin 
after absorption- Koch-Weser and Sellers (1971b) and Rabins (1972) con­
cluded that sulfonamides increase the action of coumarin anticoagulants by 
displacement of warfarin from plasma binding sites. This effect has not 
specifically been reported for sulfamethazine. Welch et al. (1969) found 
that phenylbutazone and tolbutamide competed with warfarin for binding 
sites on human plasma albumin. Further studies indicated that long-term 
pre-treatment of dogs with phenylbutazone, tolbutamide, or phénobarbital 
markedly increased the tolerance of the animals to warfarin. This pre-
treatment parallels the prior administration of oral tylosin-sulfamethazine 
or parenteral sulfamethazine employed in experimental warfarin administra­
tion. This effect is similar to the response described by Koch-Weser and 
Sellers (1971a) for hepatic microsomal enzyme inducers. 
Stowe (1955) indicated that sulfonamides are metabolized both by 
acetylation and oxidation. Furthermore, the proportion of acetylation 
versus oxidation varies with species and with type of sulfonamide. Thus, 
it seems appropriate that sulfamethazine may act to antagonize the toxic­
ity of warfarin by initially increasing the proportion of unbound warfarin 
in plasma making it more rapidly available for metabolism and excretion. 
Secondly, a microsomal enzyme induction effect resulting from prior sulfa­
methazine administration may increase the rate of warfarin metabolism to 
inactive metabolites similar to those found fay Ullrich and Staudinger 
(1968). 
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Tlio trial involving feeding of warfarin to swine in a single dose of 
1.25 mg/lb of body weight was designed to detect differences in the excre­
tion of plasma warfarin for a control versus a sulfamethazine-treated ani­
mal. The results indicate a high and prolonged plasma warfarin level for 
the control animal. This correlates with the markedly elevated prothrombin 
time, clinical hemorrhage, and death in the control animal while the sulfa­
methazine pig remained clinically healthy with near-normal prothrombin time. 
Due to the highly significant correlations among OSPT, APTT, and clot­
ting times, only OSPT or OSPT and clotting time were used subsequent to 
Trial 4 to assess the progress of coagulation factor deficiency. For the 
pig, prothrombin time appears to be a reliable and simple technique for 
screening potential coumarin poisoning in swine. 
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SUMMARY 
Pertinent literature on naturally occurring hemorrhagic diseases in 
poultry and livestock were reviewed and compared to recent outbreaks of a 
hemorrhagic syndrome in swine. Epizootiological, clinical, and hematologic 
data from porcine hemorrhagic disease suggested vitamin K-responsive hypo-
prothrombinemia. 
Warfarin was administered daily to 88 weanling pigs, either at a pre­
determined subclinical level or at a clinically toxic level. The toxicity 
of warfarin was compared in swine receiving tylosin and sulfamethazine 
antibacterial combination versus those receiving warfarin only. 
Toxicosis was induced in weanling swine fed warfarin daily at 0.025 
mg/lb body weight. Approximately 5 days were required for clinical poison­
ing to occur at that level of warfarin. Characteristic clinical signs are 
lameness, anorexia, subcutaneous hematomata, melena, and periarticular 
enlargement. 
Administration of warfarin at 0.005 and 0.0075 mg/lb did not cause 
clinical toxicosis, while 0.0125 mg/lb produced significant increases in 
One-Stage Prothrombin Time (OSPT) and Activated Partial Thromboplastin Time 
(APTT). When tylosin-sulfamethazine antibacterial combination was fed at 
normal and high levels concurrently with warfarin at 0.0075 mg/lb body 
weight, no elevation of clotting time, OSPT, or APTT was observed due to 
antibacterial action. The antibacterial combination fed alone did not pro­
duce changes in clotting time, OSPT, APTT, fibrinogen, total protein, dif­
ferential leucocyte count, or packed cell volume. 
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When toxicosis was induced by feeding warfarin at 0.025 mg/lb body 
weight, a significant protective effect was observed both from tylosin-
sulfamethazine given orally and sulfamethazine administered parenterally. 
Of two pigs given warfarin at 1.25 mg/lb body weight, the pig treated 
daily with parenteral sulfamethazine had lower plasma warfarin levels and 
returned more quickly toward normal than did the animal receiving only war­
farin. This supports the hypothesis that swine are protected from warfarin 
poisoning due to increased drug metabolism or excretion stimulated by sulfa­
methazine. 
Increases in clotting time, OSPT, and APTT correlate well with one 
another, and the OSPT would be a suitable laboratory procedure for screen­
ing potential natural vitamin K antagonists similar to dicoumarol or war­
farin. At prothrombin times approaching 30 seconds, severe clinical hemor­
rhage may be expected. 
These studies largely dispel the theory that antibiotics are detrimen­
tal tc the vitasin K or prothrombin complex status of swine. Furthermore, 
evidence was obtained to support the conclusion that tylosin-sulfamethazine 
or sulfamethazine protect or ameliorate clinical hypoprothrombinemia in 
swine exposed to warfarin. 
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